Designated Treatment ProgramSM For Families In Need
As a public service, Cord Blood Registry® (CBR) provides the Designated Treatment Program (DTP), free of charge, to families wishing to store their newborn's umbilical cord blood stem cells for a family member diagnosed with a life-threatening disease treated by stem cells. This includes diseases such as Sickle Cell Anemia and Acute and Chronic Leukemias.
This community program allows families in need, regardless of their financial situation but who meet certain medical criteria, to avail themselves of genetically related stem cells, the preferred choice by transplanters. Studies have shown that related cord blood stem cell transplants provide better survival rates than unrelated stem cell transplants, with fewer serious complications.
To date, over 15,000 cord blood transplants have been performed worldwide.
All families who meet the qualification criteria can now have access to this cutting-edge technology without any charge. There are currently nearly 3,000 patients in the DTP, with funding provided by CBR's family banking program.
How to Qualify
In order to qualify, the family member must be diagnosed with a disease that is currently treatable with donor cord blood or other hematopoietic stem cell source, be a first-degree blood relative (full-sibling or parent) to the newborn and have an oncologist/hematologist or other treating physician agree that the stem cells can be used for treatment. If eligible, CBR will provide the collection kit and process and store the newborn's cord blood sample, for 5 years without any cost to the family.
For more information on the Designated Treatment Program, please contact Cord Blood Registry at 1-888-932-6568.
* CBR is not responsible for fees charged by your caregiver or hospital associated with the collection of your newborns cord blood sample or any fees associated with shipping the sample to our laboratory.